Daily FNArena News - Australia

Sigma Pharmaceuticals has acquired 15 brands plus a manufacturing facility from BMS and announced a rights issue.

The NAB Business Survey for August showed a further improvement in conditions and confidence.

Credit markets are improving but recent results from listed REITs were mixed enough that brokers continue to have differing views on where the best exposures to the sector can be found.

The latest insitghts into job ads in Australia suggests the negative trend is turning towards a more positive outlook.

Brokers are struggling to see how Corporate Express can generate outperformance.

RBS Australia has initiated coverage on iiNet with a Buy as it sees several years of solid earnings growth ahead for the company.

While not out of the woods yet, a clear case is building for a recovery in Australian Commercial property.

The FY09 was OK, the FY10 outlook slightly disappointing, but Buys reign supreme in the broker assessments of Origin.

On Morgan Stanley’s estimates, Fortescue Metals needs to raise capital this year and any deal with the Chinese will dilute existing shareholdings.

Australian GDP rose by 0.6% in the June quarter, a better than expected result largely reflecting the impact of stimulus measures introduced by the Government.